EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update - Sorbonne Université
Journal Articles Annals of the Rheumatic Diseases Year : 2024

EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update

Maarten de Wit
Heidi Bertheussen
  • Function : Author
Peter Böhm
  • Function : Author
Catia Duarte
Marie Falahee
Joachim Sagen
  • Function : Author
Simon Stones
  • Function : Author
William Tillett
Tanita-Christina Wilhelmer
  • Function : Author
Condruta Zabalan
  • Function : Author
Jette Primdahl

Abstract

Background Since the publication of the 2011 European Alliance of Associations for Rheumatology (EULAR) recommendations for patient research partner (PRP) involvement in rheumatology research, the role of PRPs has evolved considerably. Therefore, an update of the 2011 recommendations was deemed necessary. Methods In accordance with the EULAR Standardised Operational Procedures, a task force comprising 13 researchers, 2 health professionals and 10 PRPs was convened. The process included an online task force meeting, a systematic literature review and an in-person second task force meeting to formulate overarching principles (OAPs) and recommendations. The level of agreement of task force members was assessed anonymously (0–10 scale). Results The task force developed five new OAPs, updated seven existing recommendations and formulated three new recommendations. The OAPs address the definition of a PRP, the contribution of PRPs, the role of informal caregivers, the added value of PRPs and the importance of trust and communication in collaborative research efforts. The recommendations address the research type and phases of PRP involvement, the recommended number of PRPs per project, the support necessary for PRPs, training of PRPs and acknowledgement of PRP contributions. New recommendations concern the benefits of support and guidance for researchers, the need for regular evaluation of the patient–researcher collaboration and the role of a designated coordinator to facilitate collaboration. Agreements within the task force were high and ranged between 9.16 and 9.96. Conclusion The updated EULAR recommendations for PRP involvement are more substantially based on evidence. Together with added OAPs, they should serve as a guide for researchers and PRPs and will ultimately strengthen the involvement of PRPs in rheumatology research.
Fichier principal
Vignette du fichier
2024 de wit ARD eular recos for PRPs.pdf (664.23 Ko) Télécharger le fichier
Origin Publication funded by an institution
Licence

Dates and versions

hal-04679029 , version 1 (27-08-2024)

Licence

Identifiers

Cite

Maarten de Wit, Krystel Aouad, Muriel Elhai, Diego Benavent, Heidi Bertheussen, et al.. EULAR recommendations for the involvement of patient research partners in rheumatology research: 2023 update. Annals of the Rheumatic Diseases, 2024, pp.ard-2024-225566. ⟨10.1136/ard-2024-225566⟩. ⟨hal-04679029⟩
10 View
8 Download

Altmetric

Share

More